Market Access allows stakeholders to provide a pathway using scientifically driven evidence to launch a product in the market and make it accessible to patients at the right time and the right price. Market research aids in developing an understanding of both past and contemporary markets from the viewpoint of key stakeholders. Also, it offers crucial information on the larger market scenario, your rivals, and trends influencing your business and consumers.

Our market access team assist clients to understand value of pharmaceutical products and successful product launch/reimbursement across the globe.

  • Evidence landscape for new indications in context of product access strategy
  • Competitive landscape of product
  • Payer disease primer (PDP) and Core value prospectus (CVP) for early asset development
  • Key opinion leaders (KOLs)/Stakeholders identification and mapping
  • Provide a roadmap with credible evidence for primary research, such as choice of PROs/QoL, comparators to clarify unmet need and gap assessment
  • Strength, Weakness, Opportunity and Threats (SWOT) analysis
  • Development of value dossier for policymaker and payers to showcase desired therapy benefits
  • Development of questionnaires and interview questions for potential stakeholders/KOLs
  • Scientifically sound product monograph preparation